We’re ‘Pin’novating!

PinterestU.Va. Innovation is now on Pinterest! Check out our boards, currently featuring “University Inventions That Changed the World”; our innovative products, ventures and alums; and some must-reads.

Follow us, and let us know what you’d like to see on our boards. We’re just getting started, so we’d really love your feedback.

Follow Me on Pinterest

Share
Email Facebook Twitter Linkedin

U.Va. to Co-sponsor Translational Research Forum at BIO

Expect the University of Virginia to make a splash at this year’s BIO International Convention, held in Boston.

In addition to being an exhibitor at the conference, the University is co-sponsoring the Translational Research Forum: From Bench to Bedside in a Bioeconomy – Government, Industry and the University Models to Catalyze Economic Growth and Patient Access, an opportunity to “explore how universities and their funding partners can move early stage research forward in order to make them attractive to developers.”

Our own W. Mark Crowell, executive director of U.Va. Innovation and associate vice president for research, will moderate the forum, which will feature remarks from Boston University President Robert A. Brown, Ph.D. on the role of universities in translational medicine and Bahija Jallal from MedImmune, who will discuss details of the multi-year collaboration between AstraZeneca and U.Va.

The forum will be held on Monday, June 18, from 1:30 p.m. in the Boston Exhibution and Convention Center, Room 205 BC, and will be co-sponsored by U.Va., Millennium: The Takeda Oncology Company and Investissment Quebec.

Be sure to also drop by the U.Va. booth in BIO’s ginormous exhibit hall: The University will exhibit as part of the Virginia Pavilion (Booth 2105, Pavilion Hall A).

Share
Email Facebook Twitter Linkedin

U.Va. Student Innovator Named to Canada’s “Top 20 Under 20″

Joseph Linzon

Undergraduate student inventor–entrepreneur Joseph Linzon pitches "PowerSole" at the University of Virginia's 2011 Entrepreneurship Cup. Photo by Cole Geddy.

Rising second-year Joseph Linzon, of Toronto — whom you may recognize as the “face of U.Va. Innovation,” above — has been named to Canada’s “Top 20 Under 20.” The annual program recognizes Canadian youth whose “leadership and innovation has led to the betterment of [their] school, community, province and/or country.”

Inventor of the PowerSole, a shoe that converts kinetic energy into electrical energy with each step its wearer takes, Linzon is seeking to “empower the powerless” in developing countries. The PowerSole concept came in second overall in last year’s U.Va. Entrepreneurship Cup, for which Linzon was awarded $10,000. [Read the full story.]

Congratulations, Joe!

Share
Email Facebook Twitter Linkedin

CNBC Features Local App Developer

Tobias A. Dengel, CEO of WillowTree Apps Inc.

Tobias A. Dengel, CEO of WillowTree Apps Inc., discusses the future of mobile technology. Image credit: CNBC.

Charlottesville-based app developer WillowTree Apps Inc. was featured on CNBC this week when CEO Tobias A. Dengel gave his take on the future of mobile tech outside Apple’s 2012 Worldwide Developers Conference in San Francisco. [Watch the video clip here.]

The company has built more than 100 apps for iPhone and iPad, Android, Windows Phone 7, Blackberry and Web, including “The Good Old App,” U.Va.’s official mobile application and Apple’s #1 “New and Noteworthy” education app. Among the free app’s lead features are interactive maps that allow users to search for and identify buildings on Grounds using GPS as well as push notifications for U.Va. athletics scores. [Download "The Good Old App" on iTunes and Android Market.]

Dengel, a former vice president at AOL, says WillowTree’s relationship with U.Va. extends far beyond the typical client–provider relationship. “Through our relationship with U.Va. and Darden we’ve been able to build a local tech business, have hired over 10 recent U.Va. grads, [and] have had over 15 U.Va. interns, all of which makes Charlottesville, U.Va. and WillowTree better.

“To us, this shows that U.Va. and Charlottesville can successfully take a page out of what Stanford, Harvard and others have been doing for years, and how U.Va. and Darden will hopefully continue to place a great premium on sourcing technology locally.”

Share
Email Facebook Twitter Linkedin

Innovation Roundtable: Innovation Initiatives at the FDA

U.Va. Innovation invites you to attend the May installment of our Innovation Roundtable series, Innovation Initiatives at the FDA. Please join us for a conversation with:

Kwame Ulmer
Deputy Division Director (Science and Policy)
Center for Devices and Radiological Health
U.S. Food and Drug Administration

Discover how the U.S. Food and Drug Administration is pushing new innovative efforts from within and how it is showcasing new innovation initiatives and connections. Kwame Ulmer started as a Biomedical Engineer with the FDA, then as a branch chief, and he is now the deputy director (science and policy). Prior to joining the FDA, Ulmer worked as an engineer at the Naval Sea Systems Command.

He is part of the FDA Innovation Pathway Project. Since November 2011, the team has been working to shorten the overall time it takes for the development, assessment, and review of breakthrough medical devices.

Also, come out to experience “Bump-It“, a smartphone application developed by a U.Va. student team that allows users to manage playlists by adding or stopping certain songs. “Bump-It” received an honorable mention at the 2011 U.Va. Entrepreneurship Cup.

TIME: 5 p.m. – 7 p.m.

Food and refreshments provided. The event will be held at CitySpace (100 5th St. NE) on the Downtown Mall, above the Market St. Garage.

For more information, please contact Sharon Krueger at sharonkrueger@virginia.edu or 434-243-1407.

Register online by May 15.

Share
Email Facebook Twitter Linkedin

Seminar and Q&A with John Holdren

Join us for a seminar titled “White House Grand Challenges & STEM Education” and a Q&A session featuring:

John Holdren
Assistant to President Obama for Science and Technology
Director, White House Office of Science and Technology Policy
Co‐Chair of the President’s Council of Advisors on Science and Tech.

Prior to joining the Obama administration Dr. Holdren was Teresa and John Heinz Professor of Environmental Policy and Director of the Program on Science, Technology, and Public Policy at Harvard University’s Kennedy School of Government and professor in Harvard’s Department of Earth and Planetary Science. He was also Director of the independent nonprofit Woods Hole Research Center. Previously, Holdren was a faculty at the University of California, Berkeley, where in 1973, he co‐founded, and co‐led until 1996, the interdisciplinary graduate‐degree program in energy and resources.

During the Clinton administration, Holdren served as a member of the President’s Council of Advisors on Science and Technology through both terms and chaired studies requested by President Clinton on preventing theft of nuclear materials, disposition of surplus weapon plutonium, the prospects of fusion energy, U.S. energy R&D strategy, and international cooperation on energy and technology innovation.

He holds advanced degrees in aerospace engineering and theoretical plasma physics from MIT and Stanford. He is a member of the National Academy of Sciences, the National Academy of Engineering, and the American Academy of Arts and Sciences, as well as a foreign member of the Royal Society of London and former president of the American Association for the Advancement of Science. He served as a member of the MacArthur Foundation’s Board of Trustees from 1991 to 2005, as Chair of the National Academy of Sciences Committee on International Security and Arms Control from 1994 to 2005, and as Co‐Chair of the independent, bipartisan National Commission on Energy Policy from 2002 to 2009. His awards include a MacArthur Foundation Prize Fellowship, the John Heinz Prize in Public Policy, the Tyler Prize for Environmental Achievement, and the Volvo Environment Prize. In December 1995 he gave the acceptance lecture for the Nobel Peace Prize on behalf of the Pugwash Conferences on Science and World Affairs, an international organization of scientists and public figures in which he held leadership positions from 1982 to 1997.

Where: Olsson Auditourm , Room 130 Rice Hall.

When: May 17, 2012

Time: 1:30 p.m. – 2:30  p.m.

For more information and to RSVP please contact Cheryl Wagner at cheryl-vpr@virginia.eduor 434-243-1100. The event is sponsored by the U.Va. Office of the Vice President for Research.


 

Share
Email Facebook Twitter Linkedin

U.Va. SEAS featured in Stratasys Case Study

Stratasys, a manufacturer of 3D printing and rapid prototyping systems, recently published a case study focusing on the impact of the uPrint 3D Printers and the Fortus 3D Production System on U.Va.’s rapid prototyping lab.

U.Va.’s School of Engineering and Applied Sciences began using Stratasys uPrint 3D Printers to provide students with hands-on learning. Since early 2011, the printers have become an integral part of the educational experience by providing practical opportunities for students to apply the theories they learn in the classroom.

These 3D printers foster cross-discipline projects, such as the mechatronics project. Students come together to apply their expertise in mechanical, electronic, computer, software, and control engineering with system-design to create and manufacture products. These cross-discipline application enrich students’ education and prepare them for jobs after college.

Design lab engineer at UVA’s rapid prototyping lab, Dwight Dart said, “It’s this kind of creativity and vision that makes the 3D printer an invaluable tool for our students.”

For more information about the case study, click here.

Share
Email Facebook Twitter Linkedin

Place Based Innovation: Biotech Startup Hub @ Tom Tom Festival

As part of the Tom Tom Festival’s “Place Based Innovation” series, this panel of biotech experts will examine how a biotechnology hub develops around a world-class research university like the University of Virginia. Charlottesville’s numerous biotechnology innovators are establishing start-ups in Charlottesville and one local firm has proposed redeveloping the historic Coca-Cola bottling plant on Preston Avenue into a bio-tech start-up hub. With a renewed focus on innovation at the University of Virginia, what does the future hold for biotechnology in our community?

Panelists include:

Mark Crowell, Executive Director of U.Va. Innovation and Associate Vice President for Research
Martin Chapman, CEO of Indoor Biotechnologies and head of the CityCampus Biotechnology Center
Uday Gupta, CEO of Global Cell Solutions
Nikki Hastings , Vice President, Laboratory Operations at HemoShear
Graham Anthony, CFO of Biovista

The panel will be held at The Gleason Building -(126 Garrett Street # D) on Wednesday, May 2 from 7pm to 10pm.
Share
Email Facebook Twitter Linkedin

The 4 Secrets Drug Companies Don’t Want You To Know

The pharmaceutical industry unfortunately is viewed negatively by the public, who believes that companies do little to ensure the safety of its medicines and that the main goal is to make profits at the expense of an unsuspecting public. Furthermore, people believe that drugs are really discovered in universities, research institutes or the NIH and that pharmaceutical companies simply license and manufacture new medicines. This is simply untrue. This talk will give concrete examples of the value that the pharmaceutical industry adds to the overall healthcare system. 

The talk will feature:

John LaMattina
Former Head Global R&D, Pfizer

John LaMattina

John LaMattina was the Senior Vice President, Pfizer Inc. and President, Pfizer Global Research and Development. In this role, he oversaw the drug discovery and development efforts of more than 12,000 colleagues in the United States, Europe and Asia. LaMattina joined Pfizer as a medicinal chemist in 1997 and over the years, he held positions of increasing responsibility for Pfizer Central Research, including Vice President of U.S. Discovery Operations in 1993, Senior Vice President of Worldwide Discovery Operations in 1998 and Senior Vice President of Worldwide Development in 1999.

During his tenure as Head of Global R&D, Pfizer produced new treatments for cancer, smoking cessation rheumatoid arthritis and AIDS. Dr. LaMattina is the author of numerous scientific publications, holds a number of U.S. patents and he is the author of “Drug Truths: Dispelling the Myths About Pharma R&D.” Dr. LaMattina has received a number of awards including the 1998 Boston College Alumni Award of Excellence in Science, an Honorary Doctor of Science degree from the University of New Hampshire in 2007, and the 2010 American Chemical Society Earle Barnes Award for Leadership in Chemical Research Management.

Dr. LaMattina is a Senior Partner at PureTech Ventures, he serves on the Board of Directors of Human Genome Sciences, the Board of Directors of Ligand Pharmaceuticals, and the Scientific Advisory Board of Trevena.

Co-Sponsored by HemoShear, LLC and U.Va. Innovation.

Space is limited. RSVP to Sharon Krueger at sharonkrueger@virginia.edu or 434-243-1407.

Location:
Open Grounds on University Avenue 

Event Date/Time: 
Wednesday, May 2, 2012 – 10:30 am to 11:45 am
Share
Email Facebook Twitter Linkedin

Call for Applications to 2012 SEBIO Investor Forum

The 2012 SEBIO Investor Forum connects investors and emerging companies. There will be more than 30 emerging life sciences and medical technologies companies presenting to an audience of over 350 attendees. The forum provides an opportunity for presenting companies to increase visibility to investors, industry partners, and media exposure. Early stage companies also benefit from a private advisory session with experienced business professionals. Companies also have increased access to SEBIO and the opportunity to arrange one-on-one meetings. Representatives from presenting companies will receive complimentary registration.

Date
October 31 – November 1, 2012
Location
The Breakers Palm Beach, Florida
Apply
SEBIO 2012 Investor Forum
Applications due Friday, June 29, 2012.

Share
Email Facebook Twitter Linkedin